These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
306 related items for PubMed ID: 25454826
1. Contemporary 90-day mortality rates after radical cystectomy in the elderly. Schiffmann J, Gandaglia G, Larcher A, Sun M, Tian Z, Shariat SF, McCormack M, Valiquette L, Montorsi F, Graefen M, Saad F, Karakiewicz PI. Eur J Surg Oncol; 2014 Dec; 40(12):1738-45. PubMed ID: 25454826 [Abstract] [Full Text] [Related]
2. Use of adjuvant chemotherapy in radical cystectomy patients aged >65 years: a population-based study from the surveillance epidemiology and end results (SEER)-medicare database. Schiffmann J, Sun M, Gandaglia G, Tian Z, Popa I, Larcher A, Briganti A, McCORMACK M, Shariat SF, Montorsi F, Graefen M, Saad F, Karakiewicz PI. Minerva Urol Nefrol; 2017 Apr; 69(2):173-180. PubMed ID: 27733752 [Abstract] [Full Text] [Related]
3. Marital status: a gender-independent risk factor for poorer survival after radical cystectomy. Sammon JD, Morgan M, Djahangirian O, Trinh QD, Sun M, Ghani KR, Jeong W, Jhaveri J, Ehlert M, Schmitges J, Bianchi M, Shariat SF, Perrotte P, Rogers CG, Peabody JO, Menon M, Karakiewicz PI. BJU Int; 2012 Nov; 110(9):1301-9. PubMed ID: 22449122 [Abstract] [Full Text] [Related]
5. Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer. Larcher A, Sun M, Schiffmann J, Tian Z, Shariat SF, McCormack M, Saad F, Fossati N, Abdollah F, Briganti A, Buffi N, Graefen M, Guazzoni G, Montorsi F, Karakiewicz PI. Eur J Surg Oncol; 2015 Mar; 41(3):353-60. PubMed ID: 25477269 [Abstract] [Full Text] [Related]
6. Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder. Mayr R, May M, Martini T, Lodde M, Pycha A, Comploj E, Wieland WF, Denzinger S, Otto W, Burger M, Fritsche HM. BJU Int; 2012 Sep; 110(6 Pt B):E222-7. PubMed ID: 22314129 [Abstract] [Full Text] [Related]
7. A population based assessment of perioperative mortality after cystectomy for bladder cancer. Isbarn H, Jeldres C, Zini L, Perrotte P, Baillargeon-Gagne S, Capitanio U, Shariat SF, Arjane P, Saad F, McCormack M, Valiquette L, Peloquin F, Duclos A, Montorsi F, Graefen M, Karakiewicz PI. J Urol; 2009 Jul; 182(1):70-7. PubMed ID: 19447427 [Abstract] [Full Text] [Related]
8. Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis. Abdollah F, Sun M, Jeldres C, Schmitges J, Thuret R, Djahangirian O, Tian Z, Shariat SF, Perrotte P, Montorsi F, Karakiewicz PI. BJU Int; 2012 Feb; 109(4):564-9. PubMed ID: 21810161 [Abstract] [Full Text] [Related]
9. Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy. Abdollah F, Sun M, Schmitges J, Djahangirian O, Tian Z, Jeldres C, Perrotte P, Shariat SF, Montorsi F, Karakiewicz PI. BJU Int; 2012 Apr; 109(8):1147-54. PubMed ID: 21883849 [Abstract] [Full Text] [Related]
10. Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy. Mazzone E, Nazzani S, Knipper S, Tian Z, Preisser F, Gallina A, Soulières D, Tilki D, Montorsi F, Shariat SF, Saad F, Briganti A, Wisnivesky J, Karakiewicz PI. Eur J Surg Oncol; 2019 Jul; 45(7):1253-1259. PubMed ID: 30755341 [Abstract] [Full Text] [Related]
11. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation. May M, Helke C, Nitzke T, Vogler H, Hoschke B. Urol Int; 2004 Jul; 72(2):103-11. PubMed ID: 14963349 [Abstract] [Full Text] [Related]
12. Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome. Turker P, Bostrom PJ, Wroclawski ML, van Rhijn B, Kortekangas H, Kuk C, Mirtti T, Fleshner NE, Jewett MA, Finelli A, Kwast TV, Evans A, Sweet J, Laato M, Zlotta AR. BJU Int; 2012 Sep; 110(6):804-11. PubMed ID: 22321341 [Abstract] [Full Text] [Related]
13. Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality. Lughezzani G, Sun M, Jeldres C, Alasker A, Budäus L, Shariat SF, Latour M, Widmer H, Duclos A, Jolivet-Tremblay M, Montorsi F, Perrotte P, Karakiewicz PI. Urology; 2010 Feb; 75(2):376-81. PubMed ID: 20022091 [Abstract] [Full Text] [Related]
14. Does patient age affect survival after radical cystectomy? Horovitz D, Turker P, Bostrom PJ, Mirtti T, Nurmi M, Kuk C, Kulkarni G, Fleshner NE, Finelli A, Jewett MA, Zlotta AR. BJU Int; 2012 Dec; 110(11 Pt B):E486-93. PubMed ID: 22551360 [Abstract] [Full Text] [Related]
15. Evidence from the 'PROspective MulticEnTer RadIcal Cystectomy Series 2011 (PROMETRICS 2011)' study: how are preoperative patient characteristics associated with urinary diversion type after radical cystectomy for bladder cancer? Schmid M, Rink M, Traumann M, Bastian PJ, Bartsch G, Ellinger J, Grimm MO, Hadaschik B, Haferkamp A, Hakenberg OW, Aziz A, Hartmann F, Herrmann E, Hohenfellner M, Janetschek G, Gierth M, Pahernik Sh, Protzel C, Roigas J, Gördük M, Lusuardi L, May M, Trinh QD, Fisch M, Chun FK, PROMETRICS 2011 Research Group. Ann Surg Oncol; 2015 Mar; 22(3):1032-42. PubMed ID: 25164037 [Abstract] [Full Text] [Related]
16. Radical cystectomy versus bladder-preserving therapy for muscle-invasive urothelial carcinoma: examining confounding and misclassification biasin cancer observational comparative effectiveness research. Bekelman JE, Handorf EA, Guzzo T, Evan Pollack C, Christodouleas J, Resnick MJ, Swisher-McClure S, Vaughn D, Ten Have T, Polsky D, Mitra N. Value Health; 2013 Jun; 16(4):610-8. PubMed ID: 23796296 [Abstract] [Full Text] [Related]
17. Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes. Mistretta FA, Cyr SJ, Luzzago S, Mazzone E, Knipper S, Palumbo C, Tian Z, Nazzani S, Saad F, Montanari E, Tilki D, Briganti A, Shariat SF, de Cobelli O, Karakiewicz PI. Clin Genitourin Cancer; 2020 Apr; 18(2):129-137.e3. PubMed ID: 32001182 [Abstract] [Full Text] [Related]
18. Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis. Gore JL, Lai J, Setodji CM, Litwin MS, Saigal CS, Urologic Diseases in America Project. Cancer; 2009 Mar 01; 115(5):988-96. PubMed ID: 19142878 [Abstract] [Full Text] [Related]
19. Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Koppie TM, Serio AM, Vickers AJ, Vora K, Dalbagni G, Donat SM, Herr HW, Bochner BH. Cancer; 2008 Jun 01; 112(11):2384-92. PubMed ID: 18404699 [Abstract] [Full Text] [Related]
20. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder. Liberman D, Lughezzani G, Sun M, Alasker A, Thuret R, Abdollah F, Budaus L, Widmer H, Graefen M, Montorsi F, Shariat SF, Perrotte P, Karakiewicz PI. Urology; 2011 Mar 01; 77(3):660-6. PubMed ID: 21256568 [Abstract] [Full Text] [Related] Page: [Next] [New Search]